Received Feb 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Z011449 | — |
no adverse event; GARDASIL 9 was administered to 4-month old patient.; This spontaneous report was received from a nurse and refers to a 4-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 20-JAN-2026, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant Suspension for injection (GARDASIL 9) (lot #Z011449 has been verified as valid lot number, expiration date was reported as 20-AUG-2027, but upon internal validation was established as 26-AUG-2027, exact dose, route of administration and anatomical location were not provided) for prophylaxis (Inappropriate age at vaccine administration). No symptoms/side effects reported (No adverse event).